Phase II trial to assess the biochemical efficacy of transgenic alpha(1)-anti-trypsin as an effective treatment of cystic fibrosis

Lorraine Martin, D. Downey, Joseph Elborn, D. Bilton, M. Keogan, J. Edgar

Research output: Contribution to conference › Paper › peer-review

Original language	English
Pages	A3-A3
Number of pages	1
Publication status	Published - Dec 1999
Event	Winter meeting of the British Thoracic Society - London, United Kingdom Duration: 08 Dec 1999 → 11 Dec 1999

Conference	Winter meeting of the British Thoracic Society
Country/Territory	United Kingdom
City	London
Period	08/12/1999 → 11/12/1999

Published in Thorax

Cite this

@conference{aad1a6ab354248a684008204d0b9f6cf,

title = "Phase II trial to assess the biochemical efficacy of transgenic alpha(1)-anti-trypsin as an effective treatment of cystic fibrosis",

author = "Lorraine Martin and D. Downey and Joseph Elborn and D. Bilton and M. Keogan and J. Edgar",

note = "Published in Thorax; Winter meeting of the British Thoracic Society ; Conference date: 08-12-1999 Through 11-12-1999",

year = "1999",

month = dec,

language = "English",

pages = "A3--A3",

}

TY - CONF

T1 - Phase II trial to assess the biochemical efficacy of transgenic alpha(1)-anti-trypsin as an effective treatment of cystic fibrosis

AU - Martin, Lorraine

AU - Downey, D.

AU - Elborn, Joseph

AU - Bilton, D.

AU - Keogan, M.

AU - Edgar, J.

N1 - Published in Thorax

PY - 1999/12

Y1 - 1999/12

M3 - Paper

SP - A3-A3

T2 - Winter meeting of the British Thoracic Society

Y2 - 8 December 1999 through 11 December 1999

ER -